On July 24, 2019, the World Bank announced that it had debarred a business unit of Merck Sharp & Dohme B.V. (MSD B.V.), a Dutch subsidiary of the U.S. publicly traded pharmaceutical company Merck & Co. According to the facts of the case, the MSD B.V. business unit, which successfully bid on a contract to supply contraceptives for a health systems improvement project in Bangladesh, failed to disclose the full commission amount its predecessor company had agreed to pay its local agent. The debarment is for a reduced period of twelve months as a result of MSD B.V.’s cooperation and voluntary remedial actions.
July 24, 2019
World Bank imposes 12-month debarment for fraudulent practices in connection with a Bangladeshi health development program
Related by Topic
OFAC settles with Italy-based animation company for apparent violations of DPRK sanctions
July 2, 2024
News Alert
General Court upholds EU sanctions on Russian billionaire Igor Rotenberg
June 24, 2024
News Alert
Two members of a sanctions evasion and money laundering scheme sentenced to 45 months in prison
June 13, 2024
News Alert